跳到正文
原文
Medical Xpress·· 4 小时前AI 评分30

研究发现能识别DNA结构的抗体

Research team finds an antibody that recognizes DNA shape and responds to antibiotic-induced structural changes

AI 导读

研究团队发现了一种单域抗体VHH6,能特异性识别与抗生素结合的DNA aptamer。这一发现扩展了抗体识别的范围,从蛋白质扩展到折叠的核酸结构,为分子传感提供了新方法。未来可能用于开发更灵敏的生物传感器,应用于食品安全、环境监测等领域。

正文
Saitama University research team finds an antibody that recognizes DNA shape and responds to antibiotic-induced structural changes
Researchers identified a single-domain antibody (VHH6) that preferentially recognizes an oxytetracycline-bound DNA aptamer. Credit: Nayab Khaliq et al., Saitama University, Antibodies (2026), Licensed under CC BY 4.0. https://doi.org/10.3390/antib15060107

DNA aptamers are attracting attention as alternatives to antibodies in biosensing and diagnostics. Yet little is known about whether antibodies themselves can recognize the folded structures of DNA aptamers. Researchers at Saitama University have now identified a VHH antibody that preferentially binds an oxytetracycline-associated DNA aptamer.

A DNA aptamer is a short, single-stranded DNA molecule that folds into a specific shape and selectively binds to a target, such as a protein or small chemical compound. Because of their molecular recognition capabilities, DNA aptamers are attracting growing interest as alternatives to conventional antibodies in biosensors, diagnostics and other biotechnology applications.

Most research on DNA aptamers has focused on identifying DNA molecules that recognize specific targets. However, the reverse approach—developing proteins or antibodies that recognize the three-dimensional structures of DNA aptamers—remains relatively unexplored.

Although antibodies capable of recognizing certain specialized DNA structures have been reported, identifying antibodies that recognize the diverse folded structures of single-stranded DNA aptamers presents a new challenge. Such antibodies could provide new ways to detect changes in DNA structure and potentially expand the possibilities for molecular sensing.

A research team led by specially appointed Professor Naoto Nemoto and Professor Koji Matsuoka of the Graduate School of Science and Engineering at Saitama University aimed to determine whether small, single-domain antibodies known as VHH antibodies could recognize the three-dimensional structural characteristics of DNA aptamers.

The researchers focused on a DNA aptamer that binds to oxytetracycline (OTC), an antibiotic used in veterinary medicine, and investigated how its interaction with VHH antibodies changes depending on the presence or absence of OTC.

Using cDNA display technology to screen antibody candidates, surface plasmon resonance to measure their binding properties and AlphaFold3 to predict molecular interactions, the team successfully identified a promising VHH antibody, designated VHH6, whose binding behavior is influenced by the structural characteristics of the DNA aptamer.

This study, published in the journal Antibodies, expands the scope of antibody recognition beyond proteins to folded nucleic acid structures.

"This study is interesting because it explores molecular recognition from the opposite direction to conventional DNA aptamer research," says Nayab Khaliq, a doctoral candidate and first author of the study.

"Rather than using DNA to recognize a target molecule, we investigated whether an antibody could recognize the three-dimensional features of DNA itself. Our results suggest that the folded structure of a DNA aptamer, as well as the presence of a molecule bound to it, can influence its interaction with an antibody. This opens up new possibilities for understanding and engineering protein–nucleic acid interactions."

The findings also provide a starting point for developing molecular detection systems that combine the target-binding ability of DNA aptamers with the recognition capabilities of VHH antibodies. For example, a DNA aptamer could first capture a small chemical compound, while an antibody could then recognize structural features associated with the resulting aptamer–target complex. Such an approach might eventually enable the development of a sandwich-like detection system for small molecules that are difficult to measure using conventional antibody-based assays.

Looking five to 10 years ahead, further improvements in aptamer design, antibody specificity and detection sensitivity could help translate this concept into practical biosensors for food safety, environmental monitoring and biotechnology. In particular, detecting antibiotic residues in animal-derived food products represents a potential application.

However, additional research will be necessary to develop aptamers with more pronounced target-dependent structural changes and to establish reliable analytical performance.

"Our long-term goal is to create new molecular recognition technologies by combining the strengths of DNA aptamers and antibodies," says Nemoto.

"If we can design aptamers that change their structures more distinctly when capturing small molecules, and antibodies that recognize those changes with high specificity, we may be able to create new detection tools for substances that are difficult to measure using existing methods.

"We hope this research will eventually contribute to safer food supplies, improved environmental monitoring and broader applications in molecular diagnostics."

More information

Nayab Khaliq et al., In Vitro Selection of VHH Antibodies That Recognize the Tertiary Structure of Single-Stranded DNA Aptamers, Antibodies (2026). DOI: 10.3390/antib15060107

Clinical categories

Laboratory medicine

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Research team finds an antibody that recognizes DNA shape and responds to antibiotic-induced structural changes (2026, November 20) retrieved 20 November 2026 from https://medicalxpress.com/news/2026-11-team-antibody-dna-antibiotic.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com